September 2026
The global subcutaneous drug delivery devices market size was valued at USD 38.87 billion in 2026 and is projected to hit around USD 74.66 billion by 2035 with a CAGR of 7.53%.
September 2026
The global drug and gene delivery devices market size is projected to hit around USD 1,875.96 million by 2035 from USD 864.96 million in 2026, with a CAGR of 9.00%.
September 2026
The drug delivery devices market size reached USD 321.05 billion in 2026, with leading drug delivery devices market companies including Pfizer, Inc., F. Hoffmann-La Roche Ltd, Johnson and Johnson Private Ltd.
September 2026
The global intranasal drug delivery devices market size surpassed USD 2,043.63 million in 2026 and is projected to hit around USD 4,949.45 million by 2035, with a noteworthy CAGR of 10.33%.
September 2026
The global insulin drugs and delivery devices market size is evaluated at USD 27.47 billion in 2026 and is predicted to hit around USD 52.72 billion by 2035, growing at a CAGR of 7.52%.
June 2026
The implantable drug delivery devices market size is valued at USD 13.98 billion in 2026 and is expected to hit around USD 22.01 billion by 2035 with a CAGR of 5.17%.
September 2026
The RNA interference drug delivery market was worth USD 139.58 billion in 2026, with key RNA interference drug delivery market players including Dicerna Pharmaceuticals (Acquired by Novo Nordisk), Silence Therapeutics, Ionis Pharmaceuticals.
September 2026
The pulmonary drug delivery systems market size reached USD 61.03 billion in 2026, with leading pulmonary drug delivery systems market companies including Philips Respironics, GlaxoSmithKline PLC, BoehringerIngelheim GmbH.
September 2026
The global topical drug delivery market size was valued at USD 148.81 billion in 2026 and is expected to hit around USD 324.67 billion by 2035, growing at a CAGR of 9.06%.
September 2026
The global pharmaceutical drug delivery market size was calculated at USD 2.17 trillion in 2026 and is projected to hit around USD 3.32 trillion by 2035 with a CAGR of 4.84%.
September 2026
The global nasal drug delivery technology market size is expected to surge around USD 179.41 billion by 2035 from USD 95.49 billion in 2026, growing at a CAGR of 7.28%.
September 2026
The exosome drug delivery services market size was USD 5.70 billion in 2026, with leading exosome drug delivery services market players including CD Bioarticles, Danaher, Fujifilm, Illumina.
September 2026
The global transdermal drug delivery systems market size was evaluated at USD 87.46 billion in 2026 and is predicted to hit around USD 239.43 billion by 2035, growing at a CAGR of 11.84%.
September 2026
The global liposome drug delivery market size reached USDÂ 6.63 billion in 2026 and is projected to surpass around USD 13.12 billion by 2034, with a CAGR of 8.91%.
September 2026
The next-gen delivery systems for genetic drug market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries
September 2026
The insulin delivery devices market size reached USD 22.50 billion in 2026, with leading insulin delivery devices market companies including Novo Nordisk A/S, Wockhardt Ltd., Medtronic.
September 2026
The injectable drug delivery market reached USD 829.98 billion in 2026, with prominent companies such as Sandoz, therumo, schott ag, gerresheimer, ypsormed leading the injectable drug delivery market.
July 2026
The global nanotechnology drug delivery market size was valued at USD 105.95 billion in 2025 and is expected to hit around USD 222.96 billion by 2035, growing at a CAGR of 7.72%.
May 2026
The global vaccine delivery devices market size was evaluated at USD 8.06 billion in 2025 and is predicted to hit around USD 17.10 billion by 2035, growing at a CAGR of 7.81%.
April 2026
The contraceptive drugs and devices market size reached USD 33.26 billion in 2025 and is projected to surpass around USD 58.87 billion by 2035, with a notable CAGR of 5.88%.
February 2026
The global gastro-retentive drug delivery systems outsourcing market size is expected to increase from USD 2.04 billion in 2025 to hit around USD 3.86 billion by 2035, growing at a CAGR of 6.58%.
December 2025
The global controlled release drug delivery market size is projected to hit around USD 160.09 billion by 2035 from USD 66.80 billion in 2025, with a CAGR of 9.13%.
December 2025
The advanced drug delivery market size is calculated at USD 89.83 billion in 2025 and is projected to hit around USD 371.83 billion by 2035 with a CAGR of 15.26%.
July 2026
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
August 2026
The smart pills market was valued at USD 2.49 billion in 2026, with leading companies including Medtronic, Otsuka Holdings, CapsoVision.
July 2026
The orally disintegrating tablet market size was evaluated at USD 15.73 billion in 2025 and is expected to surpass around USD 33.98 billion by 2035 with a CAGR of 8.01%.
September 2025
The global biopharmaceutical packaging market size was evaluated at USD 95.35 billion in 2024 and is predicted to hit around USD 179.66 billion by 2034, growing at a CAGR of 6.54%.
August 2025
The global PEGylation proteins technology market size was evaluated at USD 4.56 billion in 2024 and is predicted to hit around USD 9.17 billion by 2034, growing at a CAGR of 7.24%.
September 2026
The global ambulatory cardiac monitoring devices market size is estimated to hit around USD 24.58 billion by 2035 increasing from USD 9.47 billion in 2026, with a CAGR of 11.19%.
September 2026
The global laparoscopy devices market size was valued at USD 9.94 billion in 2026 and is projected to surge around USD 19.00 billion by 2035 with a CAGR of 7.46%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com